Drugs in the United States

Canadian Students for Sensible Drug Policy Tackles Harm Reduction with Next Phase of Get Sensible Youth Cannabis Education Campaign

Retrieved on: 
Thursday, April 8, 2021
Entheogens, Euphoriants, Medicinal plants, Drugs in the United States, Students for Sensible Drug Policy, Cannabis, Psychoactive drugs, Decriminalization of non-medical cannabis in the United States

Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - Canadian Students for Sensible Drug Policy ("CSSDP") announce the next phase of their Get Sensible cannabis education campaign with the launch of their website getsensible.org and two recently hosted youth-focused cannabis roundtable discussions, facilitated on March 24th and 25th.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - April 8, 2021) - Canadian Students for Sensible Drug Policy ("CSSDP") announce the next phase of their Get Sensible cannabis education campaign with the launch of their website getsensible.org and two recently hosted youth-focused cannabis roundtable discussions, facilitated on March 24th and 25th.
  • Get Sensible plans to host additional roundtables throughout 2021-22 that will focus on specific communities with deeper examination of topics relevant to their experiences.
  • So while one of the key priorities for Canada's cannabis legalization continues to emphasize protecting youth from the harmful effects of cannabis use, the Get Sensible campaign provides opportunities for young people to be engaged in co-creating and co-leading cannabis education, and supporting harm reduction in hard-to-reach youth communities.
  • Prioritizing evidence-based cannabis education projects that are youth-led, to us, is the way forward", said Get Sensible Program Manager, Sean Bristowe.

MMJ Continues Following FDA- DEA Drug Development Guidance, Federal Government Remains Opposed To Marijuana Legalization and DeScheduling

Retrieved on: 
Wednesday, March 31, 2021
Drug Enforcement Administration, Drugs in the United States, Executive branch of the United States government, Government

The US Drug Enforcement Administration has amended its regulations on March 23, 2021, to allow for additional licenses.

Key Points: 
  • The US Drug Enforcement Administration has amended its regulations on March 23, 2021, to allow for additional licenses.
  • MMJ Biopharma Cultivation has applied for a DEA license to grow marijuana as a bulk manufacturer for cannabis research.
  • The DEA has stated in their final rule, "An applicant that has manufactured marijuana without obtaining a DEA registration has violated Federal law, see 21 U.S.C.
  • MMJ Biopharma is shaping the future of the pharmaceutical marijuana industry by working with all protective government agencies in order to place public health and safety first.

Veriheal Announces $20,000 Innovation in Cannabis Higher Education Scholarship Fund

Retrieved on: 
Wednesday, March 31, 2021
Drugs in the United States, Cannabis, Cannabis in the United States, Drug policy of the United States

DENVER, March 31, 2021 /PRNewswire/ --Veriheal, the cannatech healthcare enterprise behind the nation's largest medical marijuana application platform, today announced a $20,000 Innovation in Cannabis scholarship to fund students pursuing degrees in the cannabis industry.

Key Points: 
  • DENVER, March 31, 2021 /PRNewswire/ --Veriheal, the cannatech healthcare enterprise behind the nation's largest medical marijuana application platform, today announced a $20,000 Innovation in Cannabis scholarship to fund students pursuing degrees in the cannabis industry.
  • At Veriheal, we're fortunate to be in the position to support budding entrepreneurs from all walks of life and bring diverse, fresh perspectives to the cannabis field."
  • "Veriheal has experienced triple-digit growth over the past year, scaling to become the nation's number one platform for cannabis education and medical marijuana card services.
  • Veriheal is a healthcare technology company with a mission to provide personalized cannabis education and wellness to everyone around the world.

US Legalization on the Horizon as Lawmakers Bringing Cannabis Reforms to the Senate Floor

Retrieved on: 
Monday, March 29, 2021
Cannabis smoking, Entheogens, Euphoriants, Herbalism, Medicinal plants, Cannabis, Drugs in the United States, Psychoactive drugs

In early February, multiple US Senators issued a joint statement announcing that marijuana reform bills would be merged as Congress moves toward some form of federal cannabis legalization.

Key Points: 
  • In early February, multiple US Senators issued a joint statement announcing that marijuana reform bills would be merged as Congress moves toward some form of federal cannabis legalization.
  • By mid-March, cannabis stocks surged after New York's Governor said his state was 'very close' on legalization.
  • North of the border into Canada, MYM Nutraceuticals Inc. (OTCQB:MYMMF) (CSE:MYM) has moved within one province of having nation-wide distribution across the country that legalized cannabis in October 2018.
  • "Entering the Ontario market is another key milestone for our Company," said Michael Wiener, CEO of MYM.

US Legalization on the Horizon as Lawmakers Bringing Cannabis Reforms to the Senate Floor

Retrieved on: 
Monday, March 29, 2021
Cannabis smoking, Entheogens, Euphoriants, Herbalism, Medicinal plants, Cannabis, Drugs in the United States, Psychoactive drugs

In early February, multiple US Senators issued a joint statement announcing that marijuana reform bills would be merged as Congress moves toward some form of federal cannabis legalization.

Key Points: 
  • In early February, multiple US Senators issued a joint statement announcing that marijuana reform bills would be merged as Congress moves toward some form of federal cannabis legalization.
  • By mid-March, cannabis stocks surged after New York's Governor said his state was 'very close' on legalization.
  • North of the border into Canada, MYM Nutraceuticals Inc. (OTCQB:MYMMF) (CSE:MYM) has moved within one province of having nation-wide distribution across the country that legalized cannabis in October 2018.
  • "Entering the Ontario market is another key milestone for our Company," said Michael Wiener, CEO of MYM.

3D Virtual Cannabis Conference Dates Announced

Retrieved on: 
Thursday, March 25, 2021
Cannabis, Drugs in the United States, Cannabis in Colorado, Cannabis in Washington, D.C., National Cannabis Industry Association, Cannabis industry, Cannabis in Australia, Marijuana Business Daily

DENVER, March 25, 2021 /PRNewswire/ -- Cannabis and Tech Today, one of the leading publishers of content for cannabis technology, trends, and investments, announced the spring EMERGE Virtual Cannabis Conference will be held March 30-April 1, 2021.

Key Points: 
  • DENVER, March 25, 2021 /PRNewswire/ -- Cannabis and Tech Today, one of the leading publishers of content for cannabis technology, trends, and investments, announced the spring EMERGE Virtual Cannabis Conference will be held March 30-April 1, 2021.
  • "EMERGE is a virtual reality ecosystem, that lives and breathes within the cannabis industry and culture."
  • The Emerge Virtual Cannabis Conference is hosted in partnership with industry leaders such as the National Cannabis Industry Association, the National Association of Cannabis Businesses, Regennabis, Leafwire, and the US Hemp Building Association.
  • Produced in partnership with the cannabis industry's leading media outlets and organizations, the EMERGE Virtual Cannabis Conference and Expo is currently a quarterly three-day live virtual event, leading to 90 days of continued learning, networking, and business, on one of the most experiential platforms in the world.

NuggMD Launches Its Leading Cannabis Telemedicine Services in Connecticut and Illinois

Retrieved on: 
Monday, March 22, 2021
Articles, Drugs in the United States, Assistive technology, Telehealth, Technology, Cannabis in the United States, Drug policy of the United States, Federalism in the United States, Removal of cannabis from Schedule I of the Controlled Substances Act

CHICAGO, March 22, 2021 /PRNewswire/ -- NuggMD , the nation's leading medical cannabis telemedicine platform, is launching their services in Connecticut and in Illinois.

Key Points: 
  • CHICAGO, March 22, 2021 /PRNewswire/ -- NuggMD , the nation's leading medical cannabis telemedicine platform, is launching their services in Connecticut and in Illinois.
  • Governor Lamont's March 2020 Executive Order 7L allows residents in Connecticut to receive their medical marijuana evaluation via telemedicine for the duration of the COVID emergency.
  • Illinois residents are also no longer required to obtain their medical marijuana evaluations in-person; state-licensed physicians can issue recommendations via telemedicine until further notice .
  • NuggMD is the nation's leading medical marijuana technology platform, serving patients in California, New York, Nevada, Oklahoma, Missouri, New Jersey, Pennsylvania, Ohio, Virginia, Illinois and now Connecticut.

American Cannabis Company, Inc. Announces Formation of Advisory Board

Retrieved on: 
Thursday, March 18, 2021
Herbalism, Medicinal plants, Cannabis, Drugs in the United States, Drugs, Cannabis law, Drug control law, Legality of cannabis, Medical cannabis, Cannabis in Saskatchewan, Medical cannabis in the United States

These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

Key Points: 
  • These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
  • Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations.
  • Although legalized in some states, cannabis is a Schedule 1 drug under the Controlled Substances Act (21 U.S.C.
  • This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses.

Medical Marijuana, Inc. Subsidiary HempMeds® Applauds Mexico’s Chamber of Deputies for Approving Federal Marijuana Legalization

Retrieved on: 
Wednesday, March 17, 2021
Cannabis, Drugs in the United States, Herbalism, Medicinal plants, Psychoactive drugs, Drug policy of the United States, Cannabis in the United States, Cannabis smoking, Hemp, Medical cannabis, Marijuana, Legality of cannabis by U.S. jurisdiction

Elizalde is a well-known medical cannabis advocate in Mexico and helped legalize medical cannabis in the country.

Key Points: 
  • Elizalde is a well-known medical cannabis advocate in Mexico and helped legalize medical cannabis in the country.
  • His advocacy began several years ago with his fight to gain access to CBD hemp oil for his daughter Grace.
  • Medical Marijuana, Inc.s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

American Cannabis Company, Inc. Executes Definitive Agreement to Acquire Naturaleaf™ in Southern Colorado

Retrieved on: 
Tuesday, March 16, 2021
Herbalism, Medicinal plants, Cannabis, Drugs in the United States, Drugs, Cannabis law, Drug control law, Legality of cannabis, Medical cannabis, Cannabis in Saskatchewan, Medical cannabis in the United States

These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

Key Points: 
  • These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
  • Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations.
  • Although legalized in some states, cannabis is a Schedule 1 drug under the Controlled Substances Act (21 U.S.C.
  • This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses.